|
End-of-day quote
Korea S.E.
01/10/2026
|
5-day change | 1st Jan Change | ||
| 15,920.00 KRW | +3.71% |
|
+5.22% | -18.57% |
| 09-21 | Onconic Therapeutics Inc.(KOSDAQ:A476060) added to S&P Global BMI Index | CI |
| 30/10/25 | Onconic Therapeutics Q3 operating profit 8.3 billion won, swings to profit from year earlier | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 530M | - | - | - | - | - |
| 74.41B | |||||
| 59.26B | |||||
| 47.14B | |||||
| 42.91B | |||||
| 44.13B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
